Vous êtes sur la page 1sur 4

CSR activities that impact the community

GSK makes a positive contribution to the communities in which they operate. It


invests in health and education programmes and partnerships that aim to bring
sustainable improvements to under-served people in the developed and
developing world.
Rural Initiative
-

GSK India undertakes a number of Rural Development initiatives through


its trust GRAMIN AAROGYA VIKAS SANSTHA (GAVS), a Rural Health
Development Organization. As a part of its Rural Tribal Development
mission, GSK collected primary data from 92 villages around Nashik in the
year 2005, to identify the most under-served village communities which
need support. GAVS works in 15 of the villages in Peth Taluka, Nashik
District
GSK offers Medical check-up and treatment at Trusts Mobile Van. Mobile
Clinic covers a distance of 160 kms each day and visits a cluster of five
villages in rotation, covering all 15 villages. A qualified medical
practitioner along with two healthcare workers visits the villages five days
a week.

Educational Centres
-

GAVS operates a Balwadi (pre-school) for under five year age group
children of rag-pickers community in a slum pocket called Amrapali in
Nashik. Besides inculcating good civic norms, these techniques train and
educate their minds with impact.
GAVS have also launched three Vocational Training Centers in Peth Taluka.
The centres were launched in the beginning of 2008 in collaboration with
Mumbai based partner organization, Kherwadi Social Welfare Association.
Over 700 youths have been trained and a number of them are currently
gainfully employed.
The project is undertaken with a long term objective of imparting
specialized skills and making the unemployed youths more employable in
the areas of computer literacy, tailoring, beauty training, wireman/
electrician training, increased agriculture productivity, Motor training,
nursing assistance training etc.

Shelter home for children


GSK India in collaboration with Pratham, a Non Government Organization,
started a Shelter home for children under the age of 16. This Shelter home
is located in the eastern part of India at Behraich, Lucknow, which is one of
the highest child sending regions in the country. The project aims at
prevention of children migrating to bigger cities in need of work and falling
prey to child labor and anti social elements.
-

Mid-day Meal project : GSK Pharma has been supporting the Mid-day
meal program for Municipal school students from the year 2005.

Nanhi Kali A program for education of the girl child in Kanker district,
Chattisgarh .

Access to medicines
Every year millions of people die from curable or preventable infectious diseases
or suffer unnecessary ill health because they do not have access to basic
healthcare services, including essential medicines or vaccines. There are two
main barriers in the developing world.
- Distribution network for medicines is poor.
- Poverty
To address the twin problems GSK has come up with the following approach.
- Increasing availability
GSK is trying to expand availability of its medicines and vaccines to as many of
the people who need them as possible. The company is broadening its portfolio
by introducing new products and making sure that existing products are more
widely available to the health needs of people in developing countries.
-

Improving affordability

Pricing is one factor that impacts access to medicines and vaccines.GSK wants to
ensure that the medicines are not only available but also affordable to everyone
in the world. So the company continues to take substantive steps to reform its
business practices, including adopting a range of flexible pricing models. The
company is introducing medicines in smaller pack sizes to make it more cost
effective. In the Least Developed Countries, the prices of the patented medicines
and vaccines are fixed at not more than 25% of prices in the developed
countries.

As the average price was reduced, there was a huge increase in the volume of
the vaccine sold
Preventing disease
Vaccines play a major role in preventing disease and have been acknowledged
by the WHO as being the most cost-effective of health investments. It is
estimated that at least three million deaths are prevented and 750,000 children
are saved from disability due to vaccines every year. GSK has over 30 vaccines
approved for marketing. These address the medical needs of developing and
developed countries and cover most of the leading causes of childhood mortality.
Investing in Research and Development

GSK has a specialised R&D unit dedicated to developing drugs for patients in
developing and least developed countries and championing their needs
throughout the R&D operations. GSK conducts a Focus on the Patient programme
that brings patients to GSK sites to speak directly to their R&D teams about their
healthcare needs. This helps the company to make better medicines and inspires
employees to do more to help improve patientslives. GSK is one of the few
companies researching new vaccines and treatments for all three of the World
Health Organizations priority infectious diseases, HIV/AIDS, malaria and TB.
Focus on non-communicable diseases
Non Communicable Diseases(NCDs) like Cardiovascular disease, cancer, diabetes
and chronic respiratory diseases represent 65% of the disease burden in all
countries, rich and poor and their prevalence is growing fastest in middle and
low-income countries. Increasing access to medicines for NCDs can be
particularly challenging because of the cost of providing long-term or even lifelong care. GSK is committed to finding innovative solutions to this challenge.

Key programmes
GSK is working in partnership with NGOs and other health organisations to
achieve significant and long-lasting improvements in healthcare. The various key
Programmes initiated by the company includes
Investing in developing world healthcare infrastructure:
GSK reinvests 20% of its profits from medicines and Consumer Healthcare
products into projects
that improve local healthcare infrastructure. In 2011 GSK has set up new
partnerships with AMREF, Save the Children and Care International to deliver
future investments.
Disaster response:
GSK donates cash and supplies of its products to people affected by emergencies
and natural disasters. In 2010 this included 250,000 to help the British Red
Cross provide emergency safe water and sanitation for people affected by the
Haiti earthquake and 170,000 to support communities affected by the
earthquake in Pakistan.

Bibliography
GSK Corporate Responsibility Review 2010
GSK Corporate Responsibility Report 2011
GlaxoSmithKline company profile